Subscribe: Market Wire - Medical and Healthcare: Medical Devices
http://img.marketwire.com/rss/mwMHMD.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  business  clinical  company  corporation  health  industry  leading  marketwired  medical  new  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices



Marketwired - Medical Devices



Last Build Date: Tue, 23 May 2017 03:49:10 EDT

Copyright: Copyright: (C) Marketwired
 



Zecotek Delivers Patented LFS Scintillation Crystals to Multiple High Tech Institutions

Tue, 23 May 2017 03:15:00 EDT

SINGAPORE--(Marketwired - May 23, 2017) - Zecotek Photonics Inc. (TSX VENTURE: ZMS) (FRANKFURT: W1I)(OTC PINK: ZMSPF),a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that four prestigious high tech institutions have ordered its patented LFS scintillation crystals for both medical imaging and high energy physics experiments.




Esterline Selects Joe Baddeley as President for Interface Technologies Business Group

Mon, 22 May 2017 16:05:00 EDT

BELLEVUE, WA--(Marketwired - May 22, 2017) - Esterline Corporation (www.esterline.com) (NYSE: ESL), a leading global specialty manufacturer primarily serving the aerospace and defense markets, today announced that Joe Baddeley has been selected to serve as President for the company's Interface Technologies business platform. Esterline Interface Technologies is a global group of companies specialized in human-machine interface products for applications ranging from medical services and casino gaming to rugged military and industrial input devices. The group's manufacturing and engineering facilities are located in Asia, Germany, the U.K. and the U.S., employing approximately 1,000 people.




Three Ogilvy CommonHealth Worldwide executives to speak at the 2017 e-RX and EHR Conference

Mon, 22 May 2017 15:26:51 EDT

PARSIPPANY, NJ--(Marketwired - May 22, 2017) - Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com), and a WPP Health & Wellness company (NASDAQ: WPPGY) (www.wpp.com), today announced Angelo Campano, Russell Grimaldi, and Ritesh Patel will present at the 2017 e-RX and EHR Conference on May 23-24, 2017, in Philadelphia, PA.




ADA-Required Interpreting Services Now Available Throughout the United States

Mon, 22 May 2017 13:15:17 EDT

SALT LAKE CITY, UT--(Marketwired - May 22, 2017) - Sorenson Community Interpreting Services (SCIS) is now providing onsite, in-person sign language interpreting services to U.S. businesses, medical practices, schools and other organizations that employ or serve members of the Deaf community. SCIS facilitates communication between Deaf and hearing people and customizes the communication by matching sign language interpreters' skills and expertise to each interpreting job -- whether the request is for a medical appointment, legal consultation, training seminar or performance review.




EchoPixel, Inc. Appoints Bill Carrano as Vice President of Sales

Mon, 22 May 2017 10:00:00 EDT

Industry Veteran Brings Three Decades of Experience to Visionary Medical Software




MyDx Reports First Quarter Results

Mon, 22 May 2017 09:58:42 EDT

Strong Performance of CannaDx Drives Sales Growth, Leading To Positive Cash-Flow Generation




Advantis Corp. Posts Record First Quarter Revenue

Mon, 22 May 2017 09:15:00 EDT

NEWPORT BEACH, CA--(Marketwired - May 22, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) filed its first quarter financial report today. The $119,000 of revenue reported is its highest quarterly revenue in company history.




Transonic Flowmeters Used in Development of Extra-Uterine Womb

Mon, 22 May 2017 08:30:00 EDT

Researchers used HXL Tubing Flowsensor to continuously measure circuit flow




Arch Therapeutics to Provide Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017

Mon, 22 May 2017 07:57:00 EDT

FRAMINGHAM, MA--(Marketwired - May 22, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the LD Micro Invitational, which will take place from June 6-7, 2017 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.




FrieslandCampina (Hong Kong) is awarded "HKQAA CSR Advocate Mark" by Hong Kong Quality Assurance Agency

Mon, 22 May 2017 03:00:00 EDT

HONG KONG, CHINA--(Marketwired - May 22, 2017) - FrieslandCampina (Hong Kong) Limited (FCHK) is awarded the "HKQAA CSR Advocate Mark" by Hong Kong Quality Assurance Agency (HKQAA). This award recognized FCHK's continuous efforts and outstanding contribution in corporate social responsibility.




MITRE Names Jacklyn Wynn VP, Veterans Affairs

Fri, 19 May 2017 14:02:15 EDT

MCLEAN, VA and BEDFORD, MA--(Marketwired - May 19, 2017) - The MITRE Corporation is pleased to announce that Jacklyn Mitchell Wynn has joined the leadership of The Center for Connected Government (CCG) as a Vice President and Director, leading the Department of Veterans Affairs Portfolio in the Center for Enterprise Modernization FFRDC.




The Life Sciences Report Examines How Sunesis Pharmaceuticals Shifts Focus to Leukemia Drug

Fri, 19 May 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - May 19, 2017) - In light of a decision to pull its application for approval of vosaroxin in the European Union, Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) has designated its BTK inhibitor program targeting chronic lymphocytic leukemia as its new lead program.




Propanc Biopharma Highlights PRP's Potential to Reprogram Cancer Stem Cells (CSCs)

Fri, 19 May 2017 08:30:00 EDT

MELBOURNE, AUSTRALIA--(Marketwired - May 19, 2017) - Propanc Biopharma Inc. (OTCQB: PPCH) ("Propanc Biopharma" or "the Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced that fresh new insights have emerged into how cancer stem cells (CSCs) are able to resist standard treatments, become more aggressive and spread rapidly. Published in Oncogene, by researchers from the Bellvitge Biomedical Research Institute south of Barcelona, Spain, the findings have significant implications for Propanc Biopharma's lead product PRP, which reprograms CSCs so that they are no longer malignant and a threat to the patient. PRP is a solution for once daily intravenous administration of a combination of two pancreatic proenzymes trypsinogen and chymotrypsinogen.




Ecosciences Launches Marketing of ECONOW Commercial Products With Booth At The National Restaurant Association Show

Fri, 19 May 2017 08:30:00 EDT

JERICHO, NY--(Marketwired - May 19, 2017) - Ecosciences, Inc. (OTC PINK: ECEZ) ("Ecosciences" or the "Company") is pleased to announce the kickoff of its marketing of EcoNow commercial products with its attendance as an exhibitor at the National Restaurant Association Show (https://show.restaurant.org/Home).




Using Early Economic Models in Developing your Evidence Strategy

Fri, 19 May 2017 07:30:00 EDT

The demand from regulators and payers for health economic models is increasing, as these key decision makers struggle to manage budget constraints and provide access to new therapies




General KAM Compensation Ranges From $16k to $250k, Targeted KAMs from $150k to $265k

Thu, 18 May 2017 19:45:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - May 18, 2017) - Compensation for general key account managers (KAMs) ranges from $16 thousand to $250 thousand annually depending on experience level and location, according to a recently published study by business intelligence provider Cutting Edge Information.




Relevium Provides Update on Financing and Acquistion of BioGanix

Thu, 18 May 2017 18:25:40 EDT

MONTREAL, QUEBEC--(Marketwired - May 18, 2017) - Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide an update on the acquisition of BioGanix and the related financing.




Sirrus Corp. forms Milestone Strategic Partnership with RelifyTIME for Time Verification Services

Thu, 18 May 2017 16:30:29 EDT

JOHNS CREEK, GA--(Marketwired - May 18, 2017) - Sirrus Corp. ("Sirrus" or the "Company") (OTC PINK: SRUP), an emerging cybersecurity solutions provider, today announced that the Company has entered into a Strategic Partnership Agreement with RelifyTIME LLC ("RelifyTIME").




Pediapharm annonce le lancement commercial d'Otixal(MC) au Canada

Thu, 18 May 2017 16:30:00 EDT

MONTRÉAL, QUÉBEC--(Marketwired - 18 mai 2017) -




Pediapharm Announces the Commercial Launch of Otixal(TM) in Canada

Thu, 18 May 2017 16:30:00 EDT

MONTREAL, QUEBEC--(Marketwired - May 18, 2017) -




Rennova Health Postpones Special Meeting of Stockholders to May 26, 2017

Thu, 18 May 2017 16:15:00 EDT

WEST PALM BEACH, FL--(Marketwired - May 18, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces the postponement of its Special Meeting of stockholders that was to have taken place on May 19, 2017. The postponement is necessary to achieve a quorum of shares represented at the meeting. The new date for the Special Meeting is May 26, 2017 at 11:00 a.m. Eastern time and it will take place at the offices of Shutts & Bowen LLP, 525 Okeechobee Boulevard, Suite 1100, West Palm Beach, FL 33401. The record date of April 21, 2017 remains unchanged.




Milestone Scientific Hosts Webcast with Top Key Opinion Leader to Discuss Advantages of the CompuFlo(TM) Epidural Instrument

Thu, 18 May 2017 10:30:35 EDT

LIVINGSTON, NJ--(Marketwired - May 18, 2017) - Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced a webcast presentation with Dr. Ralf Gebhard, a key opinion leader (KOL) in, Acute Pain Management and Regional Anesthesia sharing his personal and clinical trial experience with the CompuFlo Epidural Instrument and discussing its advantages and benefits in delivering superior clinical outcomes, objective documentation of clinical success, and physician productivity improvements. The webcast presentation is available on the Company's website at: http://www.milestonescientific.com/investors.html.




PAC Machinery Launches Summer Packaging Trade Show Effort, Beginning with Exhibit at EastPack, in New York City

Thu, 18 May 2017 09:30:00 EDT

PAC Machinery will increase focus on trade show participation by exhibiting at EastPack on June 13-15, 2017 at the Jacob K. Javits Convention Center - New York, NY




SystemOne Enhances Healthcare in the Developing World With Vodafone Global IoT Technology

Thu, 18 May 2017 09:00:00 EDT

Vodafone's global IoT network to enable SystemOne to transmit medical diagnostic data in real-time




Breathtec BioMedical to Investigate Zika Virus Airborne Disease Detection

Thu, 18 May 2017 09:00:00 EDT

Company pivots focus onto FAIMS Technology for new commercial applications




Savaria complète un placement privé par voie de prise ferme de 38,36 millions $ CA

Thu, 18 May 2017 08:47:47 EDT

LAVAL, QUÉBEC--(Marketwired - 18 mai 2017) - Savaria Corporation (TSX:SIS) («Savaria» ou la «Société») a le plaisir d'annoncer qu'elle a complété son placement privé par voie de prise ferme, antérieurement annoncé, de 2 760 000 reçus de souscription au prix de 13,90 $ CA par reçu de souscription (le «prix de l'offre»), pour un produit brut à Savaria totalisant 38 364 000 $ CA (l' «offre»).




Savaria Completes C$38.36 Million "Bought Deal" Private Placement

Thu, 18 May 2017 08:46:32 EDT

LAVAL, QUEBEC--(Marketwired - May 18, 2017) - Savaria Corporation ("Savaria" or the "Corporation") (TSX:SIS) is pleased to announce that it has completed its previously announced "bought deal" private placement of 2,760,000 subscription receipts at a price of C$13.90 per subscription receipt (the "Offering Price"), for gross proceeds to Savaria of C$38,364,000 (the "Offering").




Advanced Proteome Therapeutics Advances Collaborations

Thu, 18 May 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - May 18, 2017) - Advanced Proteome Therapeutics Corporation (APC) (TSX VENTURE: APC) (FRANKFURT: 0E8), a biotechnology company focused on producing technologies to perfect the use of antibody drug conjugates for the treatment of various cancers is pleased to announce they are progressing collaborations to translate their site-selective chemistries into high value antibody conjugate products.




Upcoming Webinar to Examine Rare Disease & Orphan Drug Development: Cost-Efficient Trial Design to Minimize Cash Burn

Thu, 18 May 2017 07:30:00 EDT

Despite the benefits of orphan drug development, cash burn minimization is one of the major challenges faced by developers. While guidelines exist for efficient orphan drug development, they should be adapted to challenges presented by each of the more than 7000 recognized rare diseases.




Zecotek to Jointly Develop Commercial Radiation Detection Unit with Radiation Safety and Homeland Security OEM

Thu, 18 May 2017 03:15:00 EDT

SINGAPORE--(Marketwired - May 18, 2017) - Zecotek Photonics Inc. (TSX VENTURE: ZMS)(FRANKFURT: W1I)(OTC PINK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that due to the superior performance of its patented LFS scintillation crystal the major OEM developing radiation monitoring and detection devices is moving forward with Zecotek to jointly develop a large area, commercially ready radiation detection unit.




Esterline Corporation Names Michael Covey to Board of Directors

Wed, 17 May 2017 16:05:00 EDT

BELLEVUE, WA--(Marketwired - May 17, 2017) - Esterline Corporation (NYSE: ESL), a leading specialty manufacturer serving the global aerospace and defense markets, today announced the appointment of Michael J. Covey, Chairman and Chief Executive Officer of Potlatch Corporation, to Esterline's Board of Directors, effective May 16, 2017.




Misaligned Structure of Life Science Firms May Cause Poor Medical Education Performance

Wed, 17 May 2017 12:00:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - May 17, 2017) - Life science firms allowing regional teams to design their own medical education strategies increase the risk of misaligned company strategies, according to a recently published study by business intelligence firm, Cutting Edge Information.




BioElectronics Expands into Tesco in the UK Market

Wed, 17 May 2017 11:31:26 EDT

The leading grocery retailer now stocks ActiPatch(R) Pain Therapy




GE Expands Board-Level Power Conversion Capabilities with Next-Generation DLynx* II Digital, Non-Isolated DC-DC Voltage Converters

Wed, 17 May 2017 09:30:00 EDT

Latest Additions to DLynx* Product Line Utilize Digital Features to Provide More Accurate Voltage Control and Measurement Capabilities Compared to Previous Models; High Power Density Frees up Valuable Board Space




MTBC Expands Relationship with New Jersey-based Regional Health System

Wed, 17 May 2017 09:25:00 EDT

SOMERSET, NJ--(Marketwired - May 17, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based electronic health records, practice management and mHealth solutions, today announced that Saint Clare's Health, an award-winning health system based in New Jersey, has significantly expanded its relationship with MTBC's subsidiary to include the majority of its physician groups and new service lines.




LogicStream Health Closes Series B Financing to Accelerate Growth

Wed, 17 May 2017 09:24:58 EDT

Funds will help advance the company's Clinical Process Improvement solutions and expand brand awareness




Titan Medical Completes Initial Formative Human Factors Studies for SPORT Robotic Surgical System

Wed, 17 May 2017 08:47:10 EDT

TORONTO, ON--(Marketwired - May 17, 2017) - Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), announces completion of initial formative human factors studies for its SPORT single port robotic surgical system. Formative human factors studies involve the evaluation of prototypes by expert users that focus on simulated task exercises that are critical to product safety.




VPR Brands HONEY STICK brand is sponsoring the Marijuana Business Conference and Expo

Wed, 17 May 2017 08:30:00 EDT

FORT LAUDERDALE, FL--(Marketwired - May 17, 2017) - VPR Brands, LP (OTC PINK: VPRB) will be sponsoring the Marijuana Business Conference and Expo "MJBizCon." The Company is a named sponsor for the official Show Party of MJBizCon's industry mixer and will have a table at the social event. This industry mixer will be today May 17 from 5-7pm, and VPR Brands, LP COO Daniel Hoff will be there to discuss updates within the Cannabis industry. Held by MJBizDaily, most speakers and exhibitors will be at the Mixer, as well as more than 1,000 of our industry peers. Also as part of our sponsorship package, our HONEYSTICK catalog will be included in up to 4,000 attendee gift bags that will be distributed at the show. The latest and greatest Honey Stick Products will be at the mixer event for Industry professionals to review.




Nemus Bioscience Reports Prodrug of Tetrahydrocannabinol (THC) Issued Patent Coverage in Canada and Hong Kong

Wed, 17 May 2017 08:30:00 EDT

COSTA MESA, CA--(Marketwired - May 17, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that patents have been granted in Canada and Hong Kong covering the company's proprietary prodrug of THC, THC-valine-hemisuccinate (THCVHS), as well as other amide-ester forms of cannabinoid-based molecules. These patents are licensed to Nemus by the University of Mississippi, and further broaden the potential commercial territories for THCVHS. The molecule has already received patent coverage in the United States, Japan, the United Kingdom, the European Union, and Australia. THCVHS is the active pharmaceutical ingredient (API) in Nemus' glaucoma drug candidate known as NB1111.




MediXall Group, Inc. to Offer Financing Resources to MediXaid(R) Provider Network

Wed, 17 May 2017 07:30:00 EDT

MediXall Group, Inc. and Crossroads Financial Group to offer Network Members financial assistance for growth and capital resources




5 Qualities to Consider When Selecting Clinical Pharmacology Units for Early Drug Development, New Webinar Hosted by Xtalks

Wed, 17 May 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - May 17, 2017) - On June 6, 2017 industry expert Jon Rojas, CEO of WCCT Global will discuss five qualities shared by successful clinical pharmacology units for Early Clinical Development. Additionally, he will discuss the ways in which sponsors and CROs can begin proactively encouraging their pre-approved Phase 1 sites to engage in these measures and incorporate them as standard operating procedures, ensuring that clinical pharmacology units are offering the highest value possible to their clients while still maintaining quality and safety during the conduct of any early phase clinical program. Sponsors and CROs can utilize this information and set expectations for the selection of new sites to be added to their shortlists.




Ogilvy CommonHealth Worldwide's Mary Anderson to present at the 2nd Annual Medical Affairs Pre-Launch Strategies Conference

Wed, 17 May 2017 07:00:00 EDT

PARSIPPANY, NJ--(Marketwired - May 17, 2017) - Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com) and a WPP Health & Wellness company (NASDAQ: WPPGY) (www.wpp.com), today announced Mary Anderson, president of Ogilvy CommonHealth Medical Education and SCI, Scientific Communications & Information, will lecture to medical affairs executives on incorporating multichannel resources to achieve learner-centric objectives at the 2nd Annual Medical Affairs Pre-Launch Strategies Conference in Boston, MA, on Friday, May 19.




Anticipate Increasing Adherence Budgets for Digital Patient Compliance Activities

Tue, 16 May 2017 18:30:00 EDT

Digital patient adherence investments increased by 12% since 2015




Quidel Completes Acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses

Tue, 16 May 2017 17:15:00 EDT

SAN DIEGO, CA--(Marketwired - May 16, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it completed the acquisition of the InflammaDry® and AdenoPlus® diagnostic businesses from RPS Diagnostics, a developer and manufacturer of rapid, point-of-care (POC) diagnostic tests for the eye health and primary care markets, for approximately $14 million in cash.




MyDx Releases MYDX 2.0 with an Array of Advancements as Chemical Analyzers Sold-Out in Q1 and Confirms Delivery of 1,000 Units

Tue, 16 May 2017 14:00:21 EDT

New Upgrades Further Address the Potentially False and Misleading Advertising and Labeling in the Cannabis Industry




The American Academy of Anti-Aging Medicine Introduces New Podcast: Redefining Medicine

Tue, 16 May 2017 12:37:24 EDT

BOCA RATON, FL--(Marketwired - May 16, 2017) - The American Academy of Anti-Aging Medicine will be launching its new podcast, Redefining Medicine, today. Tune in Tuesdays will host weekly sessions with key players in the field of functional and integrative medicine. The podcast will capture and spotlight the personal lives of healthcare professionals and practitioners, allowing listeners to view and hear the more intimate aspects of practicing medicine.




Kessler Foundation Among NJBIZ's 2017 Best Places to Work in New Jersey for 6th Consecutive Year

Tue, 16 May 2017 11:49:29 EDT

EAST HANOVER, NJ--(Marketwired - May 16, 2017) - Kessler Foundation, a major nonprofit organization in the field of disability, has once again been named one of NJBIZ's 2017 Best Places to Work in New Jersey -- moving up 22 spots, from #35 to #13. For the 6th consecutive year, the Foundation is recognized under the small to medium-sized organization category, 15 to 249 employees.




Pressure BioSciences, Inc. Reports First Quarter 2017 Financial Results and Provides Business Update

Tue, 16 May 2017 11:05:04 EDT

Total Revenue, Products & Services Revenue, Consumable Sales, & Gross Margins All Increased While Operating Loss Decreased, Quarter-over-Quarter; CFO Hire, CE Marking Achievement, Sales & Marketing Expansion Expected to Help Drive Revenue, Expand Customer Base, and Increase Shareholder Value Throughout FY2017




Enovacom Partners with NextGate for Unique Patient ID Management

Tue, 16 May 2017 10:00:00 EDT

Patient Record Matching Supports Consistent Identification, Master Patient Index, and Interoperability




Novus Continues Positive Business Momentum in First Quarter 2017

Tue, 16 May 2017 09:24:43 EDT

Quarterly Revenues Increased 43% Year-Over-Year; 100% Improvement in Marketing Engagement




Industry Veterans Joins XOR-Labs Toronto

Tue, 16 May 2017 09:00:00 EDT

TORONTO, ON--(Marketwired - May 16, 2017) - XOR-Labs Toronto Inc. (XOR), a spin-off from Toronto General Hospital at the University Health Network, the world's leading center for lung transplantation, and a MaRS Innovation company, announces today the addition of health care business veterans, Mr. Scott Langille as Chief Financial Officer and Mr. Joel Liederman as Senior Advisor, Planning and Pipeline, to the growing list of seasoned industry leaders that make up the XOR Business and Clinical Leadership team.




MTBC Announces Closing of $2.3 Million Registered Direct Offering Priced At-The-Market

Tue, 16 May 2017 08:30:00 EDT

SOMERSET, NJ--(Marketwired - May 16, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP) a leading provider of proprietary, cloud-based electronic health records, practice management and mHealth solutions, today announced the closing on May 15, 2017, of a registered direct offering of its common stock priced at-the-market with gross proceeds of $2.3 million.




RJD Green Inc. subsidiary, IOSOFT, announces the licensure of a patent pending "expedited check payment software platform" that provides additional synergistic payment services to their healthcare payer / provider clients

Tue, 16 May 2017 08:30:00 EDT

TULSA, OK--(Marketwired - May 16, 2017) - RJD Green Inc. (OTC PINK: RJDG) subsidiary announced today they have acquired a five year licensing agreement of a patent-pending software platform, which provides additional synergistic services and technology for current and future clients.







SANUWAVE Health Reports First Quarter Financial Results and Provides a Business Update

Tue, 16 May 2017 08:00:00 EDT

SUWANEE, GA--(Marketwired - May 16, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the three months ended March 31, 2017 and provided a business update. The Company will host a conference call at 9AM Eastern Time on Tuesday, May 16, 2017. 




31st International Research Symposium hosted by the Kinesio Taping(R) Association International

Tue, 16 May 2017 08:00:00 EDT

ALBUQUERQUE, NM--(Marketwired - May 16, 2017) - Honolulu, Hawaii will be the host for the 31st International Kinesio Taping Association International Symposium, which provides a great opportunity to learn from a diverse field of experts on how to use Kinesio Taping in your practice and for your patients. Truly a global educational event as lecturers, presenters and attendees gather in Hawaii from 30 different countries.




Choosing the Right Partner to Build a Successful Direct-to-Patient (DTP) Clinical Trial Framework, New Webinar Hosted by Xtalks

Tue, 16 May 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - May 16, 2017) - Mia Kobuta, Manager, Logistics Client Services from Sharp Clinical Services Inc. and Will Plyler, Manager of Business Development -- Clinical Research Services from McKesson Specialty Pharmacy Solutions will discuss the key aspects of a DTP program and how it works -- protocol development, clinical manufacturing/packaging, fulfillment/distribution, logistics/tracking and maintaining compliance -- with an eye to determining the trials for which it might work and choosing the best partner to support your clinical trial. The live broadcast takes place on Monday, June 5, 2017 at 11am EDT (4pm BST/UK).




Study Uncovers Disparities in Key Financial Behaviors Among Ethnic Groups in the Workforce

Tue, 16 May 2017 07:30:00 EDT

Cycle of Low Financial Wellness for many African American and Hispanic/Latino American Employees




Akers Biosciences Announces Q1 2017 Earnings

Tue, 16 May 2017 07:00:00 EDT

Significant Cost Reductions and Progress Towards Breakeven